CSTL Earnings

Quarterly EPS
$0.08
Q3 2024
$0.34
Q4 2024
$-0.90
Q1 2025
$0.16
Q2 2025
$-0.02
Q3 2025
$-0.08
Q4 2025
$-0.49
Q1 2026
$-0.07
Q2 2026
Latest Revenue103.5M
Latest Net Income-2060000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.07103.5M-2060000+20.1%-143.8%
Q1 2026-$0.4983.7M-14522000-4.9%+45.6%
Q4 2025-$0.0887.0M-2332000+0.8%-123.5%
Q3 2025-$0.0283.0M-501000-3.2%-125.0%
Q2 2025$0.1686.2M4.5M-0.9%-50.0%
Q1 2025-$0.9088.0M-25848000+20.6%-900.0%
Q4 2024$0.3486.3M9.6M+30.5%+440.0%
Q3 2024$0.0885.8M2.3M+39.5%+130.8%
Q2 2024$0.3287.0M8.9M
Q1 2024-$0.0973.0M-2534000
Q4 2023-$0.1066.1M-2580000
Q3 2023-$0.2661.5M-6905000
Castle Biosciences (CSTL) — Earnings